AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2024 Issue 1; New/Revised ICD-10-PCS Codes: Section X – New Technology

Introduction of New Therapeutic Substances

In table XW0, Introduction of Anatomical Regions, substance value 2 Talquetamab Antineoplastic has been added to body part 1 Subcutaneous Tissue to identify the subcutaneous injection of TALVEY™, a bispecific T-cell engaging antibody that is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. Bispecific antibodies (bsAbs) are a new class of drugs that can facilitate T-cell engagement without the need for patient cell collection and external manipulation.Section:           X  New Technology   Body System:  W...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .

Thank you for choosing Find-A-Code, please Sign In to remove ads.